Inventor · disambiguated record
Brandon C. P. Clavette
Also filed as: CLAVETTE BRANDON · CLAVETTE BRANDON C P
4 granted patents·6 pending applications·18 citations·filing 2016–2025
72Inventor score
Top patents by PatentIndex Score
10 records- 0191US10294303B2Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonistsAMGEN INC·Filed 2016·Granted May 21, 2019·12 cites·14 claims
- 0286US12252540B2Nucleic acid molecules encoding binding proteins for gastric inhibitory peptide receptor (GIPR)AMGEN INC·Filed 2021·Granted Mar 18, 2025·1 cites·5 claims
- 0386US11046774B2Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonistsAMGEN INC·Filed 2019·Granted Jun 29, 2021·5 cites·18 claims
- 0471US2025376529A1Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (gipr) in combination with glp-1 agonistsAMGEN INC·Filed 2025·Application pending·0 cites
- 0566US12433952B2Antibody-drug conjugates targeting folate receptor alpha and methods of useZYMEWORKS BC INC·Filed 2024·Granted Oct 7, 2025·0 cites·30 claims
- 0660US2025339552A1Antibody-drug conjugates targeting folate receptor alpha and methods of useZYMEWORKS BC INC·Filed 2025·Application pending·0 cites
- 0746US2023265202A1Antibody constructs binding 4-1bb and folate receptor alpha and uses thereofZYMEWORKS INC·Filed 2021·Application pending·0 cites
- 0844US2023052369A1Antibody constructs binding 4-1bb and tumor-associated antigens and uses thereofZYMEWORKS INC·Filed 2021·Application pending·0 cites
- 0943US2025235548A1Antibody-drug conjugates targeting napi2b and methods of useZYMEWORKS BC INC·Filed 2025·Application pending·0 cites
- 1042US2025277030A1Anti-napi2b antibodies and methods of useZYMEWORKS BC INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Brandon C. P. Clavette files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →